Mentor Capital, Inc. (MNTR) Reports 1st Quarter 2020 10-Q

Mentor Capital, Inc. (OTCQB: MNTR) announced that it had filed its quarterly Form 10-Q filing for the first quarter ended March 31, 2020, with the Securities and Exchange Commission coincident with a move to the OTCQB.

The Company reports that for the quarter ended March 31, 2020, Mentor had revenues of $1,149,462 and gross profit of $385,102, with a resulting net loss attributable to Mentor of (1.1 cents) per share. This is an increase over the prior year quarter ended March 31, 2019, in which Mentor had revenues of $1,075,995, gross profit of $370,374 and resulting net loss attributable to Mentor of (10.4 cents) per share.

In the quarter ended March 31, 2020, the Company invested an additional $35,334 into a Legal Recovery Purchase Agreement with Electrum Partners, LLC, increasing total legal funding involvement to $575,574. This funding supports their action against Aurora Cannabis Inc., Defendant, pending in the Supreme Court of British Columbia.

As further disclosed in our Form 10-Q, most of the remaining equipment leased to G Farma was repossessed by the Company and sold for $222,031. The remainder of repossessed equipment is held for sale in Company storage with an estimated net realizable value of $40,000. For the approximate $1,045,051 G Farma notes receivable plus the $1,055,680 G Farma finance lease payments remaining, we will continue to pursue legal recovery for breach of contract for non-payment from G Farma and its guarantors.

The effect of the novel coronavirus pandemic (“COVID-19”) has significantly impacted the economy and could materially impact the Company’s business and stock price. Our legal recovery efforts have been and may be further hindered due to the closure of the courts in California and British Columbia, delaying our legal recovery from the G Farma entities and the Company’s interest in the Electrum Partners, LLC legal recovery.

Public health efforts to mitigate the impact of the pandemic could impact our 51% owned subsidiary, Waste Consolidator, Inc. (“WCI”), if its client businesses cannot collect rents and pay WCI invoices. The ultimate impact of COVID-19 on our business is dependent on future developments which are uncertain and cannot be predicted at this time.

Subsequent to quarter end, on April 23, 2020, Mentor received a forgivable Paycheck Protection Program loan of $76,500 from the U.S. Small Business Administration (“SBA”). On May 6, 2020, WCI received a forgivable Paycheck Protection Program loan of $383,342 from the SBA.

Since 2016 the Company’s 100% owned subsidiary, Mentor IP, LLC, has owned a 15.7% interest in a pending United States vape patent application for the delivery during vaping of various percentage concentrations of THC, CBD and other cannabinoids. The patent was granted on January 21, 2020, and issued on May 5, 2020. Additionally, Mentor IP, LLC owns 41.4% of any Canadian patent applications and patents that are derived from the U.S. parent application. On March 23, 2020, Mentor IP, LLC applied for expedited prosecution with the Canadian Intellectual Property Office under the Patent Cooperation Treaty Patent Prosecution Highway Program based on the claims allowed in the corresponding United States vape patent.

The Company had 11,494 shareholders reported as of March 31, 2020, with 22,850,947 shares issued. At March 31, 2020, there were 87,456 Series B warrants outstanding with an exercise price of $0.11 per share, 6,252,954 Series D warrants outstanding with an exercise price of $1.60 per share, and 689,159 Series H warrants that are held by an investment bank at a $7.00 per share exercise price. No equity was granted to directors, insiders, consultants or investor relations firms during the eight quarters ending March 31, 2020. A long-term 300,000 share repurchase plan was authorized in 2014 and, at March 31, 2020, a total of 44,748 shares have been repurchased under the long-term plan. The Company’s shares finished the quarter at a closing price of $0.09 per share representing a market capitalization of $2,056,585 compared to a 2019 year end closing price of $0.12 per share and a corresponding market capitalization of $2,742,114. Mentor’s Series Q Preferred Stock, first sold at $10,000 per share on May 30, 2018, were exchangeable for approximately $14,977 per share in Mentor common shares on March 31, 2020.